# Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

> **NCT01339949** · NA · WITHDRAWN · sponsor: **Oraya Therapeutics, Inc.**

## Conditions studied

- Wet Age-related Macular Degeneration
- Age-related Macular Degeneration
- AMD
- Wet AMD
- Macular Degeneration

## Interventions

- **DEVICE:** IRay
- **DEVICE:** IRay

## Key facts

- **NCT ID:** NCT01339949
- **Lead sponsor:** Oraya Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-06
- **Primary completion:** 2012-10
- **Final completion:** 2014-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision to withdraw study to pursue others.
- **Last updated:** 2011-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339949, "Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01339949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*